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SUMMARY
Wnt/b-catenin signaling is required for embryonic
stem cell (ESC) pluripotency by inducing meso-
dermal differentiation and inhibiting neuronal differ-
entiation; however, how b-catenin counter-regulates
these differentiation pathways is unknown. Here, we
show that lysine 49 (K49) ofb-catenin is trimethylated
(b-catMe3) by Ezh2 or acetylated (b-catAc) by Cbp.
Significantly, b-catMe3 acts as a transcriptional co-
repressor of the neuronal differentiation genes sox1
and sox3, whereas b-catAc acts as a transcriptional
co-activator of the key mesodermal differentiation
gene t-brachyury (t-bra). Furthermore, b-catMe3
and b-catAc are alternatively enriched on repressed
or activated genes, respectively, during ESC and
adult stem cell differentiation into neuronal or meso-
dermal progenitor cell lineages. Importantly, expres-
sion of a b-catenin K49A mutant results in major
defects in ESC differentiation. We conclude that
b-catenin K49 trimethylation and acetylation are
key elements in regulating ESC pluripotency and
differentiation potential.
INTRODUCTION
Historically, b-catenin was first identified in association with the
cell adhesion molecule E-cadherin (Vestweber and Kemler,
1984). In the cadherin-catenin adhesion complex, b-catenin
binds directly to the cytoplasmic domain of E-cadherin and me-
diates via a-catenin the anchorage to the actin-based cytoskel-
eton (Ozawa et al., 1989). During recent years, a second role of
b-catenin in the Wnt signaling pathway became increasingly
apparent (Nelson and Nusse, 2004).
The canonical Wnt signaling pathway plays a major role in em-
bryonic stem cell (ESC) and adult stem cell differentiation, and
dysregulation of this pathway is frequently observed in human
cancers (Reya and Clevers, 2005). b-Catenin is a central compo-
nent of the Wnt pathway, acting as a transcriptional co-activator
with LEF/TCF transcription factors to control target gene expres-
sion.Wnt/b-catenin signaling is required for pluripotency in order
to maintain ESCs in the undifferentiated state (ten Berge et al.,
2011; Ying et al., 2008), the induction of mesodermal differentia-
tion (Gadue et al., 2006), and, at the same time, inhibition of
neuronal differentiation (Haegele et al., 2003; Kielman et al.,
2002; Verani et al., 2007). These findings suggest a complex
role forb-catenin function indirectingopposing cell fates inESCs.
It is well known that gene expression is controlled by changes
in post-translational modifications of histones, such as methyl-
ation by the polycomb repressive complex 2 (PRC2). Methyl-
transferases (Ezh1 and Ezh2) in the PRC2 complex modify lysine
27 of histone 3 (H3K27Me3) (Morey and Helin, 2010), and
H3K27Me3 represses developmentally regulated genes (O’Car-
roll et al., 2001; Sparmann and van Lohuizen, 2006) and is
required for stem cell differentiation (Pasini et al., 2007). Ezh2
also mediates methylation of non-histone proteins in a PRC2-
independent manner (He et al., 2012; Kim et al., 2013), and an
interaction of Ezh2 with the canonical Wnt signaling pathway
has been reported (Jung et al., 2013).
Here, we show that b-catenin is in complex with PRC2 compo-
nents in ESCs and that it is trimethylated by Ezh2 at K49. Impor-
tantly, we show that b-catMe3 represses neuronal differentiation
genes sox1 and sox3. b-Catenin K49 has also been reported to
be acetylated by CREB-binding protein (Cbp) (Wolf et al.,
2002), and we show the acetylation of K49 by Cbp is involved
in the activation of the mesodermal differentiation gene t-bra.
Taken together, our data indicate that post-translational modifi-
cation of K49 of b-catenin functions as a molecular switch for
b-catenin function, determining whether it acts as a co-activator
or a co-repressor. We hypothesize that this pathway for regu-
lating b-catenin function is important for maintaining ESC plurip-
otency and differentiation potential.
RESULTS
Ezh2 Methylates b-Catenin at Lysine 49
Using a SILAC-based approach to search for nuclear interac-
tion partners of b-catenin, we identified several components of
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the PRC2 complex (Hoffmeyer, 2012). This interaction was
verified by the co-immunoprecipitation of b-catenin with
Suz12 and Ezh2, but not Jarid2, from nuclear extracts of
ESCs (Figure 1A). Recombinant b-catenin also pulled-down
Ezh2 (Figure 1B) and Suz12 (not shown), but not Jarid2 or
Eed (Figure S1A), from ESC lysates. Significantly, b-catenin
was identified as a substrate of Ezh2 using an in vitro methyl-
ation assay with PRC2 and recombinant b-catenin (Figure 1C),
and b-catenin deletions indicated that the methylation site was
within exon 3 of the b-catenin gene (Figure 1D). Within exon 3,
K19 and K49 are possible targets for methylation, and we
identified K49, not K19, as the site using a K > R mutation
that blocked b-catenin methylation by PRC2 (Figure 1E).
Significantly, a b-cat-K49A mutant was mono- and dimethy-
lated but not trimethylated (Figure 1F). Attempts to demon-
strate methylation by mass spectrometry were not successful,
because trypsin cannot digest K49 of b-catenin when it is
methylated.
b-Catenin K49 is close to well-characterized phosphorylation
sites for CK1a (T45) and GSK3b (S33, S37, T41), indicating a
possible molecular cross-talk between phosphorylation and
methylation. Furthermore, methylation of b-catenin by Ezh2 at
K49 may activate Wnt/b-catenin signaling (Zhu et al., 2016).
However, and ignored in this previous report, K49 is acetylated
FE
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Figure 1. Ezh2 Methylates b-Catenin at Lysine 49
(A) b-catenin co-purifies with components of the PRC2 complex Ezh2, Suz12, and Jarid2 from nuclear extracts of ESCs.
(B) In vitro-translated Ezh2 associates with glutathione S-transferase (GST)-b-catenin.
(C) Autoradiography showing in vitro methylation of GST-b-catenin incubated with active PRC2 complex and S-adenosyl-L-methionine, S-[methyl-3H] (SAM[3H]).
Ponceau stain shows input.
(D) Species alignment of amino acids encoded by exon 3 of b-catenin; the position of K19 and K49 is conserved among species.
(E) In vitro methylation of GST-b-catenin or GST-b-catenin carrying lysine (K)-to-arginine (R) mutations at K19 or K49 with active PRC2 complex and SAM. Left:
detection of methylated lysines and total b-catenin by immunoblot. Right: quantification of two independent experiments using ImageJ software.
(F) GFP-b-catenin wild-type (Gfp-b-cat WT) or K49A mutation transfected into Hek 293 cells. Gfp-Trap followed by detection of trimethylated or methylated
lysines and b-catenin by immunoblot.
2816 Cell Reports 18, 2815–2824, March 21, 2017
AB
C
D
E
F
G
(legend on next page)
Cell Reports 18, 2815–2824, March 21, 2017 2817
by Cbp (Wolf et al., 2002). Thus, post-translational modification
of K49 by either acetylation or methylation may be biologically
relevant to the function of b-catenin.
Monoclonal Antibodies Specific for Methylated and
Acetylated Lysine 49 Reveal Complex Specificity for
b-catMe3
To gain further insight into the role of these b-catenin modi-
fications, we raised rat monoclonal antibodies specific for
b-catenin K49 methylation (mAb-K49-Me3) (Figure 2A) and
acetylation (mAb-K49-Ac) (Figure 2B). A monoclonal antibody
that recognized unmodified, acetylated, mono- and trimethy-
lated b-catenin (mAb-b-cat-total) was used as a control
(Figure S1D).
The specificity of mAb-K49-Me3 and mAb-K49-Ac was
tested. First, Hek293 cells transiently expressing Gfp-tagged
wild-type b-catenin (Gfp-b-cat WT) or b-catenin in which K49
was substituted by alanine (Gfp-b-cat K49A) were co-trans-
fected with either Ezh2 or Cbp. Western blotting of cell lysates
showed that mAb-K49-Me3 and mAb-K49-Ac detected
b-catMe3 and b-catAc, respectively, but not Gfp-b-cat K49A
(Figures 2C and D). Co-expression of Ezh2 enhanced the level
of b-catMe3 (Figure 2C), and b-catAc was detected upon co-
expression of Cbp (Figure 2D). Second, mAb-K49-Me3 and
mAb-K49-Ac immunoprecipitated b-catMe3 and b-catAc,
respectively, from nuclear extracts of mouse ESCs (Figure 2E).
Third, mAb-K49-Me3 and mAb-K49-Ac detected b-catMe3
and b-catAc in immunoblots of whole cell lysates from Hek293
cells and the human carcinoma cell line, SW480 (Figure S1C).
Fourth, mAb-K49-Me3 and mAb-K49-Ac did not immunoprecip-
itate b-catMe3 and b-catAc following inhibition of Ezh2 or Cbp
enzymatic activity with the specific inhibitors Gsk343 and ana-
cardic acid, respectively (Figures 2E and S1B). However, mAb-
K49-Me3 detected b-catMe3, albeit at a greatly reduced level,
in ESCs deficient for Ezh2 (Ezh2/) (Figure S2A), indicating
that other HKMTs may contribute to b-catenin trimethylation.
Indeed, Ezh1 can trimethylate b-catenin (Figure S2C), and a dou-
ble null for Ezh1 and Ezh2 resulted in no detectable b-catMe3
(Figures S2B and S2D).
We had shown previously that b-catenin associated with
Ash1, a component of the MLL complex (Hoffmeyer et al.,
2012). However, Ash21 and b-catMe3 did not co-immunoprecip-
itate (Figure 2F). In contrast, b-catMe3 co-immunoprecipitated
with the PRC2 complex components Ezh2, Suz12, and Jarid2
(Figure 2G). Together, these results indicate strongly that Ezh2
trimethylates b-catenin at K49 in cells, which is detected with
mAb-K49-Me3.
Post-translationally Modified b-Catenin Is Differentially
Enriched at Promoter Regions of Key Developmental
Genes
b-Catenin is the main transcriptional co-activator in the Wnt/
b-catenin signaling pathway. Because both b-catMe3 and
b-catAc were detected in the nuclei of ESCs (Figures 2E and
2F), we investigated the role of these post-translational modifica-
tions of b-catenin K49 in the transcriptional regulation of b-cate-
nin target genes in mouse ESCs.
WT and b-catenin-deficient (b-Cat/) ESCs were treated with
either Wnt3a or the Wnt-mimicking reagent CHIR99021. After
48 hr, cells were collected and mRNA levels of the mesodermal
marker gene t-brachyury (t-bra), and the neuronal marker genes
sox1 and sox3 were measured. The mRNA levels of the t-bra
were markedly increased after Wnt3a or CHIR99021 treatment,
whereas the mRNA levels of sox1 and sox3 were strongly
reduced (Figures 3A and S3A, left panels). These changes in
mRNA expression were dependent on b-catenin expression
(Figures 3A and S3A, right panels).
We tested whether these changes in t-bra, sox1, and sox3
mRNA levels were due to a direct interaction with either b-catAc
or b-catMe3. Chromatin immunoprecipitation (ChIP) experi-
ments with mAb-K49-Me3, mAb-K49-Ac, and mAb-b-cat-total
revealed a direct association of b-catMe3 with all three pro-
moters in untreated WT ESCs (Figure 3B). Importantly, after
CHIR99021 treatment, b-catMe3 was depleted from the t-bra
promoter region but remained on the sox1 and sox3 promoters
(Figure 3C). As a control for the mAb-K49-Me3 antibody, ChIP
was performed in GSK343-treated WT ES and b-Cat/ and
Ezh2/ ESCs (Figure 3C). ChIP of Ezh2, Suz12, and Eed re-
vealed that PRC2 core components and b-catMe3 were bound
to the same promoter regions in a CHIR99021-dependent
manner (Figures S3D–S3F) with H3K27Me3 (Figure S3B).
After induction of the Wnt pathway with CHIR99021, b-catAc
was selectively detected at the t-bra promoter region, but
not at the sox1 or sox3 promoter regions (Figure 3B), with
H3K27Ac (Figure S3C). ChIP with mAb-b-cat-total to detect un-
modified, acetylated, and methylated b-catenin revealed that
b-catenin was present on all three promoters, and there was
no change in levels after CHIR99021 treatment of WT ESCs.
b-Catenin was also detected in Ezh2/ ESCs. b-Cat/ ESCs
were used as a negative control (Figure 3D).
In summary, CHIR99021-dependent induction of t-bra (Fig-
ures 3A and S3A) correlated with the enrichment of b-catAc
and H3K27Ac (Figures 3B and S3C), but the depletion of trime-
thylated H3K27, b-catMe3, and PRC2 complex components
(Figures 3C, S3B, and S3D–S3F) at the t-bra promoter region.
Figure 2. Monoclonal Antibodies Specific for Methylated and Acetylated Lysine 49 Reveal the Specificity of PRC2 Complex for b-catMe3
(A and B) Characterization of rat mAbs against methylated (mAb-K49-Me3) and acetylated (mAb-K49-Ac) b-catenin. Dot blots with peptide competition assays
for antibody specificity; mAb-K49-Me3 (A) and mAb-K49-Ac (B).
(C and D) Gfp-b-cat WT or Gfp-b-cat K49A co-transfected with Ezh2 (C) or Cbp (D) in Hek 293 cells. Immunoblot of 20 mg total protein lysate probed with mAb-
K49-Me3 and Ezh2 (C) or mAb-K49-Ac and HA (D), b-catenin and b-tubulin (C and D).
(E) Immunoprecipitations with mAb-K49-Me3 (top) and mAb-K49-Ac (bottom) from nuclear extracts of ESCs. Inhibition of Ezh2 by treatment with Gsk343 fol-
lowed by immunoblot with mAb-K49-Me3 and b-catenin (bottom). Inhibition of Cbp by treatment with anacardic acid followed by immunoblot with mAb-K49-Ac
and b-catenin (bottom).
(F and G) Co-immunoprecipitations with Suz12 (F, left), Ash2l (F, right), and mAb-K49-Me3 (G). Immunoblot with mAb-K49-Me3, b-catenin, Suz12, and Ash2l
(F and G); Ezh2 and Jarid2 (G). b-catMe3 is only detectable in complex with PRC2 (F and G).
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In contrast, the CHIR99021-dependent decrease in sox1 and
sox3 mRNA levels (Figures 3A and S3A) correlated with the
enrichment of b-catMe3, Ezh2, Suz12, Eed, and H3K27Me3 at
the sox1 and sox3 promoter regions (Figures 3C, S3B, and
S3D–S3F).
Localization of b-catMe3 and b-catAc on Target Genes
during ESC Differentiation
ESCsweredifferentiated into neuronal ormesodermal progenitor
cells (Figures S4A andS4B), and the enrichment of b-catMe3 and
b-catAc at the t-bra, sox1, and sox3 promoter regions was
analyzed by ChIP. In mesodermal progenitor cells, high levels
of t-bra mRNA (Figure S4A) correlated with the enrichment of
b-catAc (Figure 3E) and H3k27Ac (Figure S4E) at the t-bra pro-
moter region,whereasb-catMe3 (Figure 3E) andH3K27Me3 (Fig-
ure S4F) were enriched on the promoters of the neuronal marker
genes sox1 and sox3. In contrast, in the neuronal progenitor cells
high levels of sox1 and sox3mRNAs (Figure S4B) correlated with
the enrichment of b-catAc (Figure 3F) and H3k27Ac (Figure S4E)
at the promoter regions of the sox1 and sox3 genes, whereas
b-catMe3 (Figure 3F) and H3K27Me3 (Figure S4F) were detected
at the t-bra promoter. ChIP experiments with mAb-b-cat-total
detected equal levels of b-catenin at the three promoter regions
in both mesodermal and neuronal progenitor cells (Figure S4D).
These results provide compelling evidence that b-catenin post-
translationally modified at K49 is bound to the promoters of key
genes involved in ESC development, and there is a change
from K49 trimethylation in mesodermal progenitor cells to acety-
lation in neuronal progenitor cells.
We extended these studies to primary neurosphere cultures
isolated from newborn mice (Figure S4C). ChIP analysis with
mAb-K49-Me3, mAb-K49-Ac, and mAb-b-cat-total revealed a
binding pattern of the post-translationally modified forms of
b-catenin to the t-bra, sox1, and sox3 promoters that were
similar to those in differentiated ESCs (Figures 3G and S4G).
The enrichment of H3K27Ac and H3K27Me3 correlated with
the enrichment of mAb-K49-Me3, mAb-K49-Ac, respectively
(Figures S4H and S4I). Taken together, these results show that
post-translationally modified forms of b-catenin K49 correlated
with mesodermal and neuronal differentiation of ESCs and adult
stem cells.
Lysine 49 Mutations Affect ESC Pluripotency and
Differentiation
Next, we analyzed the biological relevance of post-translational
modification of b-catenin K49 using the b-catenin K49A loss-of-
function mutant in ESCs. Gfp-b-catenin fusion proteins (Gfp-
b-cat WT or Gfp-b-catK49A) were expressed in b-catflox/
ESCs and the endogenous b-catenin allele was simultaneously
deleted (scheme shown in Figure S5A). Gfp-positive (Gfp-b-cat
WT or Gfp-b-cat K49A) clones were analyzed by fluorescence-
activated cell sorting (FACS), and clones that expressed levels
of b-catenin comparable toWTESCswere selected (Figure S5C).
All b-Gfp-b-cat WT clones exhibited typical ESC morphology,
although Gfp-b-cat K49A clones grew more rapidly and in a
more dispersed manner than Gfp-b-cat WT clones (Figure S5B).
Analysis of t-bra, sox1, and sox3 mRNA levels in Gfp-b-cat
K49A clones revealed a decrease in t-bra mRNA levels and an
increase in sox1 and sox3mRNA levels (Figure 4A). Thus, substi-
tution of K49 by alanine was sufficient to alter the expression
of the key developmental differentiation genes t-bra, sox1, and
sox3. Based on this finding, Gfp-b-cat K49A cells were sub-
jected to in vitro differentiation for 4 days. Differentiation to
mesodermal progenitor cells was examined by comparing levels
of t-bra, tbx6, and msgn1 mRNAs. As expected, Gfp-b-cat WT
cells exhibited strong induction of t-bra, tbx6, and msgn1
mRNAs at day 4, whereas Gfp-b-catK49A failed to induce these
mesodermal markers (Figure S5E). Differentiation into neuronal
progenitor cells was examined by comparing levels of sox1
and sox3 mRNAs. Gfp-b-cat WT cells induced these neural
markers, whereas Gfp-b-catK49A cells exhibited high levels
of sox1 and sox3 expression at day 0 (d0) (Figure 4A) that did
not increase further during neuronal progenitor differentiation
(Figure S5D).
To obtain a more global view of changes in gene expression
in Gfp-b-cat K49A clones, we used transcriptome expression
profiling. We compared two ESC clones of Gfp-b-cat WT or
Gfp-b-cat K49A that were either undifferentiated or differentiated
into mesodermal or neuronal progenitor cells (Figures 4B and
4C). Undifferentiated Gfp-b-cat K49A cells differentially ex-
pressed genes associated with ESC pluripotency and differenti-
ation. A subset of differentially regulated genes is shown is Fig-
ure 4B. During differentiation, Gfp-b-cat K49A cells did not
induce the expression of genes involved in mesodermal differen-
tiation (group I), such as cdx2 and t-bra. Others were neither
induced in mesodermal or neuronal differentiation in Gfp-b-cat
K49A cells (group II). Interestingly, many genes where upregu-
lated selectively in mesodermal and neuronal differentiation in
Gfp-b-cat K49A cells (group III). A subset of differentially regu-
lated genes is shown in Figure 4C.
To examine in vivo differentiation potential, teratomas were
produced in nude mice from the parental cell line b-Catflox/
Figure 3. b-catMe3 and b-catAc Are Differentially Enriched at the Promoter Regions of Key Developmental Genes in ES Cells and during
Differentiation
(A) qPCR analysis of t-bra, sox1, and sox3mRNA levels. In WT ESCs, Wnt3a reduces sox1 and sox3 expression and induces t-bra expression (left). In (b-cat/)
ESCs, Wnt3a has no effect on the expression levels of these genes (right). Bars represent n = 3 ± SEM.
(B–D) ChIP of t-bra, sox1, and sox3 promoters in untreated and CHIR99021-treated ESCs using mAb-K49-Ac (B), mAb-K49-Me3 (C), and mAb-b-cat-total (D).
b-catMe3 and b-catAc are differentially enriched on the t-bra, sox1, and sox3 promoters (B andC). For the total amount of b-catenin, no changes in enrichment are
observed (D). After Gsk343 treatment no enrichment of b-catMe3 is detectable (C). No enrichment of b-catAc is induced (B). ChIP in anacardic acid (AA)-treated
ES is used as negative control for mAb-K49-Ac (B). mAb-b-cat-total ChIP reveals that b-catenin is enriched at target gene promoters in Ezh2/ cells (D). In mAb-
K49-Me3 ChIP, no b-catMe3 can be detected at target gene promoters in Ezh2/ ESCs (C). b-cat/ ESCs are used as negative control (B–D).
(E–G) ESCs are differentiated for 4 days to mesodermal progenitors (mp d4) (E) or neuronal progenitors (np d4) (F). (E–G) ChIP in mp d4 (E), np d4 (F), and in neural
stem (NS) cells (G) using mAb-K49-Ac and mAb-K49-Me3. b-catMe3, and b-catAc are differentially targeted to the lineage-specific promoters t-bra, sox1, and
sox3. Surb7 is used as a negative control region (B–G). Bars represent n = 6 ± SEM. Statistically significant p values: *p% 0.05 and **p% 0.01 (B–G).
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Figure 4. Lysine-49 Mutations Affect ES Cell Pluripotency and Differentiation; b-catMe3 Complexes with E-Cadherin at the Cell Membrane
(A) qPCR of t-bra, sox1, and sox3 mRNA in b-cat/CreERT2 Gfp b-cat WT and K49A ESCs. Gfp b-cat K49A ESCs show increased expression of sox1 and sox3
mRNA compared with Gfp b-cat WT ESCs, whereas t-bra mRNA levels is reduced in Gfp b-cat K49A cells.
(legend continued on next page)
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and from the Gfp-b-cat WT and Gfp-b-cat K49A cell lines. The
parental cell line developed into benign, differentiated teratomas
composed of various tissue-like structures derived from the
three germ layers (not shown). In contrast, Gfp-b-cat WT and
Gfp-b-cat K49A produced relatively immature teratocarcinomas
that showed notable differences in the appearance of differenti-
ated structures. Tumors derived from Gfp-b-cat WT cells con-
tained epithelia with keratinization and mesenchymal deriva-
tives, whereas tumors from Gfp-b-cat K49A cells exhibited
predominantly neuro-rosette and neurotube-like structures
with no sign of other differentiated derivatives (Figure 4D). The
Gfp-b-cat K49A tumors expressed the neuronal markers Nf-
160 and b-III-tubulin at much higher levels than the Gfp-b-cat
WT tumors (Figure 4D). Markers for mesodermal or ectodermal
cells were barely detected in Gfp-b-cat K49A tumors (not
shown). However, Gfp-b-cat K49A tumors failed to downregu-
late the stem cell markers SSEA-1 and Oct4, and high levels
of expression of both markers could be detected (Figure 4D).
In addition, Gfp-b-cat K49A tumors were highly proliferative
(Figure 4D).
Taken together, our in vitro and in vivo analyses demonstrate
that post-translational modifications of b-catenin K49 are essen-
tial for the correct expression of key developmental genes. Mu-
tation of K49 to alanine resulted in deregulation of t-bra, sox1,
and sox3 mRNAs in ESCs, and consequently, these cells failed
to differentiate into mesodermal progenitor cells and differenti-
ated into neuronal structures.
Methylated b-Catenin Is Associatedwith the E-Cadherin
Cell Adhesion Complex
We detected strong nuclear staining of b-catMe3 in both the tro-
phectoderm and the inner cell mass (ICM) of mouse E3.5 blasto-
cysts (Figure 4E). Surprisingly, b-catMe3 was detected at the
plasmamembrane, particularly at trophectodermal cell-cell con-
tacts (Figure 4E). Cell surface immunoprecipitation of E-cad-
herin-catenin cell adhesion complexes with an antibody directed
against the extracellular domain of E-cadherin revealed the pres-
ence of b-catMe3, but not b-catAc (Figure 4F). b-catMe3was not
detected in a complex with E-cadherin after treatment with the
Ezh2-specific inhibitor Gsk343 (Figure 4F).
Next, we determined when b-catenin became trimethylated
during its biosynthesis and intracellular transport in a complex
with E-cadherin (Ozawa and Kemler, 1992). Using an antibody
against the precursor polypeptide portion of E-cadherin, we
showed that b-catMe3, but not b-catAc, was present in a com-
plex with the E-cadherin precursor polypeptide (Figure 4G).
These results provide convincing evidence that trimethylation
of K49 is a very early event in b-catenin biosynthesis.
DISCUSSION
Wnt/b-catenin signaling is required to induce ESC mesodermal
differentiation and inhibit neuronal differentiation, but how b-cat-
enin regulates both of these differentiation pathways at the same
time has been unclear. Here, we showed that b-catenin is trime-
thylated (b-catMe3) by Ezh2 or acetylated (b-catAc) by Cbp. We
generated antibodies specific for b-catMe3 and b-catAc and
showed in co-immunoprecipitation experiments that b-catMe3
is specifically present in a complex with PRC2 but not with
Ash2l, a core component of the Trx group of proteins (Schuetten-
gruber et al., 2011). These modified forms of b-catenin provide a
link between Wnt/b-catenin signaling and the PRC2 chromatin-
modifying complex.
b-Catenin is a substrate of PRC2 complex component Ezh2,
which trimethylates b-catenin exclusively at K49 (b-catMe3).
Dimethylation of b-catenin occurs at several lysine residues in
armadillo repeats 4 and 5, which might regulate b-catenin stabil-
ity (Lu et al., 2015). However, K49 is the only lysine acetylated
by Cbp (Wolf et al., 2002), suggesting to us that K49 has a spe-
cific biological function. It is possible that Ezh2 and Cbp indi-
rectly affect b-catenin stability by modifying components of the
destruction complex.
It is well established that Wnt/b-catenin signaling inhibits the
neuronal differentiation of ESCs (Haegele et al., 2003; Kielman
et al., 2002; Verani et al., 2007). However, it was unclear whether
b-catenin directly repressed neuronal differentiation genes.
Here, we showed that b-catenin directly represses the neuronal
differentiation genes sox1 and sox3 and that this was depen-
dent on b-catenin trimethylation by Ezh2. Both Wnt3a and
CHIR99021 treatment caused a strong b-catMe3-dependent
decrease in sox1 and sox3 mRNA levels, at the same time as
an increase in mRNA level of the mesodermal differentiation
gene t-bra.
Our studies revealed the mechanism by which modified forms
of b-cateninmay counter-regulate neuronal andmesodermal dif-
ferentiation gene expression. We showed that in the absence of
(B and C) Heatmap of expression levels of a subset of genes differentially regulated in b-cat/CreERT2 Gfp b-cat K49A ESCs compared to b-cat/CreERT2 Gfp
b-catWT ESCs (B), and after 4 days of differentiation tomp d4 or np d4 (C). Group I: mesoderm-specific genes not induced in K49Amutantmp d4. Group II: genes
not induced in K49Amutant in mp d4 and np d4. Group III: genes induced in K49Amutant in mp d4 and np d4 (C). The data used to generate the heatmaps can be
found in Tables S2 and S3.
(D) Immunohistochemical and immunofluorescent staining of 4-week teratomas derived fromGfp b-cat WT and Gfp b-cat K49A ESCs. H&E reveals the presence
of keratinization and mesenchymal derivatives in Gfp b-cat WT tumors, whereas Gfp-b-cat K49A tumors exhibit predominantly neuro-rosette and neurotube-like
structures. Nf-160 and b-III-tubulin staining indicate strong induction of neuronal differentiation in Gfp-b-cat K49A tumors. Retention of pluripotency markers in
Gfp-b-cat K49A tumors is determined by measurement of SSEA-1 and Oct4 levels. Scale bars, 200 mm; insets, 50 mm. Filled arrowheads indicate positive
staining. Open arrowheads indicate negative areas.
(E) Immunofluorescence with mAb-K49-Me3 reveals high nuclear levels of b-catMe3 in the trophectoderm and in the ICM of E3.5 blastocysts. In addition,
b-catMe3 is detected at the cell membrane. Scale bars, 20 mm.
(F) Cell surface immunoprecipitation with E-cadherin antibody against the extracellular domain in ESCs treated with DMSO (left) or Gsk343 (right). b-catMe3, but
not b-catAc, is detectable in a complex with E-cadherin (left). After Gsk343 treatment, b-catMe3 is undetectable (right).
(G) Co-immunoprecipitation with E-cadherin precursor polypeptide in ESCs reveals that b-catMe3, but not b-catAc, is present in complexes containing the
E-cadherin precursor polypeptide. Immunoblot using mAb-K49-Ac and mAb-K49-Me3 against E-cadherin and b-catenin (F and G).
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induction of the Wnt pathway b-catMe3, Ezh2 and H3K27Me3
were all enriched at sox1, sox3, and t-bra promoters. However,
following activation of Wnt signaling with CHIR99021, b-catMe3,
Ezh2, and H3K27Me3 were depleted from the t-bra promoter,
whereas b-catAc and H3K27Ac were selectively enriched there.
Significantly, b-catAc remained undetectable on the neuronal
target gene promoters sox1 and sox3, while b-catMe3, Ezh2,
and H3K27Me3 were retained there, keeping the promoters in
a repressed state. Based on these results, we propose that
acetylation of K49 (b-catAc) is induced upon activation of the
Wnt/b-catenin signaling pathway, whereas trimethylation of
K49 (b-catMe3) may act upstream of Wnt signaling because
b-catMe3 is detectable in the absence of ectopic Wnt induction.
Thus, a b-catMe3 and polycomb-dependent repressive mecha-
nismmay act as a default pathway to maintain ESC pluripotency
by repression of neuronal differentiation. Remarkably, upon in-
duction of Wnt signaling, b-catMe3 and b-catAc binding to
sox1, sox3, and t-bra promoters is mutually exclusive and corre-
lates with induction of neuronal and mesodermal differentiation
pathways. We showed that in the presence of Wnt signaling,
b-catMe3 is replaced by b-catAc at the sox1 and sox3 pro-
moters, an event that coincides with the induction of sox1 and
sox3 gene expression and the neuronal differentiation pathway.
However, in mesodermal progenitor cells, b-catMe3 remains
at the promoter regions of sox1 and sox3, and b-catAc is en-
riched at the t-bra promoter region, resulting in b-catMe3-
dependent suppression of the neuronal differentiation pathway
and b-catAc-dependent activation of the mesodermal pathway.
This finding clearly indicates that post-translational modification
of a single amino acid residue (K49) of b-catenin directs the pro-
tein to regulate either gene repression or gene activation. Thus,
the activities of methyltransferases/demethylases and acetyl-
transferases/deacetylases must dynamically controlled to regu-
late these b-cateninmodifications and binding to the promoter of
differentiation-specific genes.
The importance of methylation and acetylation of b-catenin
K49 in regulating ESC differentiation was further demonstrated
by expressing a K49A mutant in an endogenous b-catenin null
background. Teratocarcinoma tumors bearing the K49A muta-
tion exhibited a strong tendency toward the formation of
neuronal structures, which we interpret, based on our results,
as a loss of b-catMe3 binding to neuronal differentiation genes
(e.g., sox1, sox3) that normally suppresses their expression.
Alternatively, this result may be due to insufficient induction
of mesoderm differentiation during tumor growth, as sug-
gested by the absence of t-bra mRNA and other mesodermal
markers during in vitro differentiation. It will be of interest to
replace K49 with an amino acid residue that can mimic
methylation.
In addition to the strong enrichment of modified forms of
b-catenin in the nucleus, we also found b-catMe3 in the cyto-
plasm and at the cell membrane in the E-cadherin cell adhesion
complex, and this interaction occurred early in the biosynthesis
of the complex. Interestingly, b-catAc was barely detectable in
the adhesion complex. More work is needed to characterize
the function of methylated b-catenin at the cell membrane.
Lysine methylation of non-histone proteins is increasingly recog-
nized (Moore and Gozani, 2014; Zhang et al., 2012). Recently, it
was reported that Ezh2 methylates the integrin-associated pro-
tein talin, which influences integrin-dependent adhesion and
migration of cells (Gunawan et al., 2015).
In conclusion, our study provides a basis for understanding
the molecular mechanisms through which b-catenin mediates
ESC pluripotency and directs mesodermal differentiation. We
describe a b-catenin function in ESCs that provides a molecular
link between b-catenin and the epigenetic chromatin modifiers
Ezh2 and Cbp, both of which partially exert their function on
target gene chromatin through the modification of b-catenin.
EXPERIMENTAL PROCEDURES
Hybridoma Production
The peptide sequence: TAPSLSG-K-GNPEEEDVDTC-amid (Biosyntan GmbH
Berlin) with the marked lysine tri-, mono-, or acetylated was coupled to malei-
mide-activated bovine serum albumin (BSA, for immunization), or ovalbumin
(OVA, for ELISA), both purchased from Thermo Scientific. Lewis rats received
six times 50 mg peptide, 100 mg CpG ODN 2006 (Imagenex), and incomplete
Freund’s adjuvant (GIBCO, BRL) subcutaneously (s.c.) in weekly intervals.
Spleen cells and peripheral lymph nodes were fused with SP2o myeloma cells
with polyethylene glycol 1500 (Roche) using standard conditions.
Chromatin Immunoprecipitation
ChIP experiments were performed as described (Hoffmeyer et al., 2012). The
following antibodies were used: 5 mg of mAb-b-cat-total (produced in house),
mAb-K49-Me3 (produced in house), Ezh2 (Diagenode), Suz12 (Cell Signaling),
and Eed (Santa Cruz), 3 mg of mAb-K49-Ac (produced in house), and 2 mg of H3
(Abcam), H3K27Me3 (Abcam), or H3K27Ac (Abcam).
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